Horsham, PA, July 13, 2017 ― Janssen Biotech, Inc. (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for the treatment of adults living […]
when scientists in New Zealand discovered that a meningitis vaccine fortuitously protects against gonorrhoea, they were benefiting from an unpredictable force responsible for some of history’s most striking medical breakthroughs: […]
July 7, 2017 — The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe […]
The research and development unit of Fanavar Mobtaker Caspian Pharmaceutical Company has announced that it is finishing the final stages of making the injectable form of the naproxen drug.
The research and development unit of the Fanavar Mobtaker Caspian pharmaceutical company has announced its readiness to attract researchers from all over the world in the fields of chemistry and pharmaceuticals.